
    
      This study was an open label randomized multi-centre phase II trial in patients with
      inoperable locally advanced stage IIB-IIIB Non Small Cell Lung Cancer who fulfils the general
      criteria for curatively intended irradiation. The treatment plan consisted of two courses of
      inductions chemotherapy followed of concomitant therapy chemo-radiotherapy 3 weeks after day
      1 of the last induction chemotherapy has been given. The patients was included in the study
      after completing the induction chemotherapy. Randomization took place only if an acceptable
      dose plan could be obtained.

      Primary endpoint: local recurrence free interval
    
  